Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 132INDUSTRY 78NIH 31NETWORK 18OTHER_GOV 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Capecitabine 9Bevacizumab 8tislelizumab 7Oxaliplatin 7Drug Therapy 7pembrolizumab 6Standard of Care 6Surgical Procedures, Operative 5Radiotherapy 5Laparoscopy 5Fluorouracil 5Docetaxel 5Cisplatin 5Carboplatin 5Radiosurgery 4Leucovorin 4Exercise 4Epirubicin 4Cyclophosphamide 4toripalimab 3pertuzumab 3durvalumab 3dalpiciclib 3atezolizumab 3anlotinib 3Saline Solution 3Rituximab 3Prednisone 3Population Groups 3Observation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Prednisone × 1 year × Clear all
NCT04433156 2026-04-09

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Henan Cancer Hospital

Phase 2 Completed
26 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT06421948 2025-12-05

Linperlisib Combined With Chidamide in Patients With PTCL

Henan Cancer Hospital

Phase 1/2 Recruiting
134 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT04214626 2025-11-19

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡